Cruciferous vegetables: Dietary phytochemicals for cancer prevention

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1565-1570

  Abdull Razis, Ahmad Faizal ^a   Mohd Noor, Noramaliza ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Carcinogen; Chemopreventive; Cruciferous vegetables; Glucosinolates; Isothiocyanates

Indexed keywords

EID: 84880400731     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1565     Document Type: Short Survey

References (55)

1. Abdull Razis AF, Bagatta M, De Nicola GR, et al (2012a). Characterisation of the temporal induction of hepatic xenobiotic-metabolising enzymes by glucosinolates and isothiocyanates: Requirement for at least a 6-hour exposure to elicit complete induction profile. J Agri Food Chem, 60, 5556-64.
2. Abdull Razis AF, Bagatta M, De Nicola GR, et al (2010). Intact glucosinolates modulate hepatic cytochrome P450 and phase II conjugation activities and may contribute directly to the chemopreventive activity of cruciferous vegetables. Toxicol, 277, 74-85.
3. Abdull Razis AF, De Nicola GR, Pagnotta E, et al (2012b). A glucosinolate-rich extract of Japanese Daikon perturbs carcinogen-metabolizing enzyme systems in rat, being a potent inducer of hepatic glutathione S-transferase. Eur J Nut, 12, 2.
4. Abdull Razis AF, De Nicola GR, Pagnotta E, et al (2012c). 4-Methylsulfanyl-3-butenyl isothiocyanate derived from glucoraphasatin is a potent inducer of rat hepatic phase II enzymes and a potential chemopreventive agent. Arch Toxicol, 86, 183-94.
5. Abdull Razis AF, Bagatta M, De Nicola GR, et al (2011a). Induction of epoxide hydrolase and glucuronosyl transferase by isothiocyanates and intact glucosinolates in precision-cut rat liver slices: importance of side chain substituent and chirality. Arch Toxicol, 85, 919-27.
6. Abdull Razis AF, Bagatta M, De Nicola GR, et al (2011b). Up-regulation of cytochrome P450 and phase II enzyme systems in rat precision-cut rat lung slices by the intact glucosinolates, glucoraphanin and glucoerucin. Lung Cancer, 71, 298-305.
7. Abdull Razis AF, Hanlon N, Soltys E, et al (2012d). The naturally-occurring aliphatic isothiocyanates sulforaphane and erucin are weak agonists but potent non-competitive antagonists of the aryl hydrocarbon receptor. Arch Toxicol, 86, 1505-14.
8. Abdull Razis AF, Konsue N, Dervetzoglou M, et al (2011c). Phenethyl isothiocyanate, a naturally-occurring phytochemical, is an antagonist of the aryl hydrocarbon receptor. Mol Nutr Food Res, 55, 1-10.
9. Abdull Razis AF, Iori R, Ioannides C (2011d). The natural chemopreventive phytochemical R-sulforaphane is a far more potent inducer of the carcinogen-detoxifying enzyme systems in rat liver and lung than the S-isomer. Int J Cancer, 128, 2775-82.
10. Ambrosone CB, McCann SE, Freudenheim JL, et al (2004). Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr, 134, 1134-8.
11. Bacon JR, Williamson G, Garner RC, et al (2003). Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis, 24, 1903-11.
12. Bhattacharya A, Tang L, Geng F, et al (2010). Inhibition of bladder cancer development by allyl isothiocyanate. Carcinogenesis, 31, 281-6.
13. Bheemreddy RM, Jeffery EH (2007). The metabolic fate of purified glucoraphanin in F344 rats. J Agric Food Chem, 55, 2861-6.
14. Brown KK, Hampton MB (2011). Biological targets of isothiocyanates. Biochimica et Biophysica Acta, 1810, 888-94.
15. Clarke JD, Hsu A, Riedl K, et al. (2011). Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res, 64, 456-63.
16. Cramer JM, Teran-Garcia M, Jeffery EH (2012). Enhancing sulforaphane absorption and excretion in healthy men through the combined consumption of fresh broccoli sprouts and a glucoraphanin-rich powder. Brit J Nutr, 107, 1333-8.
17. Cwik MJ, Wu H, Muzzio M, et al (2010). Direct quantitation of glucoraphanin in dog and rat plasma by LC-MS/MS. J Pharmaceut Biomed Analysis, 52, 544-9.
18. Fahey JW, Zalcmann AT, Talalay P (2001). The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochem, 56, 5-51.
19. Getahun SM, Chung F-L (1999). Conversion of isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol Biomark Prev, 8, 447-51.
20. Goosen TC, Kent UM, Brand L, et al (2000). Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables. Chem Res Toxicol, 13, 1349-59.
21. Guo Z, Smith TJ, Wang E, et al (1992). Effect of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobioticmetabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis, 13, 2205-10.
22. Hanlon N (2009a). The chemopreventive potential of sulforaphane and erucin. Faculty of Health and Medical Sciences, University of Surrey. Personal communication.
23. Hanlon N, Coldham N, Gielbert A, et al (2008a). Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in the rat. Brit J Nut, 99, 559-64.
24. Hanlon N, Okpara M, Coldham N, et al (2008b). Modulation of rat hepatic and pulmonary cytochromes P450 and phase II enzyme systems by erucin, an isothiocyanate structurally related to sulforaphane. J Agric Food Chem, 56, 7866-71.
25. Hanlon N, Poynton CL, Coldham N, et al (2009b). The aliphatic isothiocyanates erucin and sulforaphane do not effectively up-regulate NAD(P)H: quinone oxidoreductase (NQO1) in human liver compared with rat. Molec Nutr Food Res, 53, 836-44.
26. Hecht SS, Carmella SG, Murphy SE (1999). Effects of watercress consumption on urinary metabolites of nicotine smokers. Cancer Epidemiol Biomarkers Prev, 8, 907-13.
27. Holst B, Williamson G (2004). A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep, 21, 425-47.
28. Ioannides C, Lewis DFV (2004). Cytochromes P450 in the bioactivation of chemicals. Curr Topics Medicinal Chem, 4, 1767-88.
29. Ioannides C, Hanlon N, Konsue N (2010). Isothiocyanates: a chemical class of potential nutraceuticals. The Open Nutraceuticals J, 3, 55-62.
30. Joseph MA, Moysich KB, Freudenheim JL, et al (2004). Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1 and prostate cancer risk. Nutr Cancer, 50, 206-13.
31. Kassahun K, Davis M, Hu P, et al (1997). Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Am Chem Soc, 10, 1228-33.
32. Köhle C, Bock KW (1989). Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem. Pharmacol, 77, 686-99.
33. Konsue N (2010a). Pharmacokinetics and chemopreventive potential of phenethyl isothiocyanate. Faculty of Health and Medical Sciences, University of Surrey.
34. Konsue N, Ioannides C (2010b). Phenethyl isocyanate is not the metabolite of phenethyl isothiocyanate responsible for mechanism-based inhibition of cytochrome P450. Arch Toxicol, 84, 751-9.
35. Konsue N, Ioannides C (2008). Tissue differences in the modulation of rat cytochromes P450 and phase II conjugation systems by dietary doses of phenethyl isothiocyanate. Food Chem Toxicol, 46, 3677-83.
36. Konsue N, Ioannides C (2010c). Modulation of carcinogenmetabolising cytochromes P450 in human liver by the chemopreventive phytochemical phenethyl isothiocyanate, a constituent of cruciferous vegetables. Toxicol, 268, 184-90.
37. Konsue N, Ioannides C (2010d). Differential response of four human livers to modulation of phase II enzyme systems by the chemopreventive phytochemical phenethyl isothiocyanate. Mol Nutr Food Res, 54, 426-32.
38. Krull C, Humblot C, Philippe C, et al (2002). Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Carcinogenesis, 23, 1009-16.
39. Lam TK, Gallicchio L, Lindsley K, et al (2009). Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev, 18, 184-95.
40. Lee M-S (1996). Enzyme induction and oxidative desulfuration of isothiocyanates to isocyanates. Chem Res Toxicol, 9, 1072-8.
41. McGregor DI, Mullin WJ, Fenwick GR (1983). Analytical methodology for determining glucosinolate composition and content. J Assoc of Anal Chem, 66, 825-49.
42. Moore LE, Brennan P, Karami S, et al. (2007). Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the central and Eastern European kidney cancer study. Carcinogenesis, 28, 1960-4.
43. Nakajima M, Yoshida R, Shimada N, et al (2001). Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Met Disp, 29, 1110-3.
44. Namkung MJ, Yang HL, Hulla JE, et al (1988). On the substrate specificity of cytochrome P450IIIA1. Mol Pharmacol, 34, 628-37.
45. Robbins RJ, Keck AS, Banuelos G, et al (2005). Cultivation conditions and selenium fertilisation alter the phenolic profile, glucosinolate, and sulforaphane content of broccoli. J Med Food, 8, 204-14.
46. Safe SS (2001). Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett, 120, 1-7.
47. Skupinska K, Misiewicz-Krzeminska I, Stypulkowski R, et al (2009). Sulforaphane and its analogues inhibit CYP 1A1 and CYP 1A2 activity induced by benzo(a)pyrene. J Biochem Mol Toxicol, 23, 18-28.
48. Sones K, Heaney RK, Fenwick GR (1984). An estimate of the mean daily intake of glucosinolates from cruciferous vegetables in the UK. J Sci Food Agric, 35, 712-20.
49. Steinbrecher A, Nimptsch K, Husing A, et al (2009). Dietary glucosinolate intake and risk of prostate cancer in the EPICHeidelberg cohort study. Int J Cancer, 125, 2179-86.
50. Ye L, Zhang Y (2001). Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of phase 2 detoxification enzymes. Carcinogenesis, 22, 1987-92.
51. Yoxall V, Kentish P, Coldham N, et al (2005). Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: implications for its chemopreventive activity. Int J Cancer, 117, 356-62.
52. Zhang Y, Callaway EC (2002). High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J, 364, 301-07.
53. Zhang Y, Talalay P (1998). Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res, 58, 4632-39.
54. Zhao H, Grossman HB, Hernandez LM, et al (2007). Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer, 120, 2208-13.
55. Zhu CY, Loft S (2003). Effect of chemopreventive compounds from Brassica vegetables on NAD(P)H:quinone reductase and induction of DNA strand breaks in murine hepa1c1c7 cells. Food Chem Toxicol, 41, 455-62.